📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis. (2021)

First Author: Reis TAR

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.exppara.2020.108059

PubMed Identifier: 33338468

Publication URI: http://europepmc.org/abstract/MED/33338468

Type: Journal Article/Review

Volume: 221

Parent Publication: Experimental parasitology

ISSN: 0014-4894